Mark Vanderpump

9.6k total citations · 2 hit papers
57 papers, 5.4k citations indexed

About

Mark Vanderpump is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mark Vanderpump has authored 57 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mark Vanderpump's work include Thyroid Disorders and Treatments (32 papers), Thyroid Cancer Diagnosis and Treatment (20 papers) and Growth Hormone and Insulin-like Growth Factors (10 papers). Mark Vanderpump is often cited by papers focused on Thyroid Disorders and Treatments (32 papers), Thyroid Cancer Diagnosis and Treatment (20 papers) and Growth Hormone and Insulin-like Growth Factors (10 papers). Mark Vanderpump collaborates with scholars based in United Kingdom, Denmark and Australia. Mark Vanderpump's co-authors include David R. Appleton, J.M. French, F. K. E. Tunbridge, W. M. G. Tunbridge, F. CLARK, E. T. Young, David Bates, David Hasan, J. Grimley Evans and Helen Rodgers and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Mark Vanderpump

55 papers receiving 5.1k citations

Hit Papers

The incidence of thyroid ... 1995 2026 2005 2015 1995 2011 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Vanderpump 4.3k 631 574 521 502 57 5.4k
Nils Knudsen 4.0k 0.9× 693 1.1× 425 0.7× 403 0.8× 285 0.6× 75 4.7k
Trine Bjøro 3.0k 0.7× 425 0.7× 384 0.7× 736 1.4× 696 1.4× 119 5.1k
Francesco Trimarchi 3.8k 0.9× 543 0.9× 529 0.9× 711 1.4× 891 1.8× 227 5.5k
Rhoda H. Cobin 5.3k 1.2× 716 1.1× 607 1.1× 494 0.9× 599 1.2× 37 6.9k
Peter Taylor 2.5k 0.6× 705 1.1× 384 0.7× 300 0.6× 600 1.2× 124 4.2k
Jacqueline Jonklaas 5.4k 1.3× 407 0.6× 668 1.2× 1.3k 2.5× 738 1.5× 105 6.6k
Clark T. Sawin 4.4k 1.0× 458 0.7× 395 0.7× 558 1.1× 659 1.3× 106 5.5k
Roberto Negro 5.4k 1.3× 620 1.0× 258 0.4× 706 1.4× 404 0.8× 110 6.8k
Jayne A. Franklyn 5.6k 1.3× 775 1.2× 1.4k 2.4× 923 1.8× 1.1k 2.2× 116 7.5k
Bijay Vaidya 3.6k 0.8× 699 1.1× 1.1k 2.0× 417 0.8× 398 0.8× 127 5.3k

Countries citing papers authored by Mark Vanderpump

Since Specialization
Citations

This map shows the geographic impact of Mark Vanderpump's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Vanderpump with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Vanderpump more than expected).

Fields of papers citing papers by Mark Vanderpump

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Vanderpump. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Vanderpump. The network helps show where Mark Vanderpump may publish in the future.

Co-authorship network of co-authors of Mark Vanderpump

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Vanderpump. A scholar is included among the top collaborators of Mark Vanderpump based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Vanderpump. Mark Vanderpump is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okosieme, Onyebuchi, Jackie Gilbert, Kristien Boelaert, et al.. (2021). Thyrotoxicosis and hyperthyroidism: causes, diagnosis and management. Pharmaceutical journal/˜The œpharmaceutical journal.
2.
Vanderpump, Mark, et al.. (2019). Iodine and folate—essential for mothers to be. The Lancet Diabetes & Endocrinology. 8(1). 9–10. 3 indexed citations
3.
Baldeweg, Stephanie E, Mark Vanderpump, Will Drake, et al.. (2016). SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of pituitary apoplexy in adult patients. Endocrine Connections. 5(5). G12–G15. 29 indexed citations
4.
Parretti, Helen M., Onyebuchi Okosieme, & Mark Vanderpump. (2016). Current recommendations in the management of hypothyroidism: developed from a statement by the British Thyroid Association Executive. British Journal of General Practice. 66(651). 538–540. 15 indexed citations
5.
Vanderpump, Mark. (2014). Thyroid and iodine nutritional status: a UK perspective. Clinical Medicine. 14(6). s7–s11. 12 indexed citations
6.
Garg, Aakash & Mark Vanderpump. (2013). Subclinical thyroid disease. British Medical Bulletin. 107(1). 101–116. 39 indexed citations
7.
Vanderpump, Mark. (2011). The epidemiology of thyroid disease. British Medical Bulletin. 99(1). 39–51. 767 indexed citations breakdown →
8.
Razvi, Salman, J. Weaver, Mark Vanderpump, & Simon H. S. Pearce. (2010). The Incidence of Ischemic Heart Disease and Mortality in People with Subclinical Hypothyroidism: Reanalysis of the Whickham Survey Cohort. The Journal of Clinical Endocrinology & Metabolism. 95(4). 1734–1740. 197 indexed citations
9.
Rodondi, Nicolas, Patrick Maisonneuve, Salman Razvi, et al.. (2010). SUBCLINICAL HYPOTHYROIDISM AND THE RISK OF CORONARY HEART DISEASE AND MORTALITY: AN INDIVIDUAL PARTICIPANT DATA ANALYSIS FROM NINE PROSPECTIVE COHORT STUDIES. Leiden Repository (Leiden University). 1 indexed citations
10.
Vanderpump, Mark, C S Higgens, & John Wass. (2010). UK guidelines for the management of pituitary apoplexy a rare but potentially fatal medical emergency. Emergency Medicine Journal. 28(7). 550–551. 10 indexed citations
11.
Rajasekaran, Senthil, Mark Vanderpump, Stephanie E Baldeweg, et al.. (2010). UK guidelines for the management of pituitary apoplexy. Clinical Endocrinology. 74(1). 9–20. 247 indexed citations
12.
Vanderpump, Mark. (2009). How should we manage patients with mildly increased serum thyrotrophin concentrations?. Clinical Endocrinology. 72(4). 436–440. 9 indexed citations
13.
Madge, Sara, Colette Smith, Fiona Lampe, et al.. (2007). No association between HIV disease and its treatment and thyroid function. HIV Medicine. 8(1). 22–27. 37 indexed citations
14.
Smellie, W S A, et al.. (2007). Best practice in primary care pathology: review 11. Journal of Clinical Pathology. 61(4). 410–418. 11 indexed citations
15.
Vanderpump, Mark, Mark Easton, Daryll Baker, et al.. (2004). Achieving compliance with the European Working Time Directive in a large teaching hospital: a strategic approach. Clinical Medicine. 4(5). 427–430. 11 indexed citations
16.
Baldeweg, Stephanie E, et al.. (2003). Use of Continous glucose monitoring system in the medical management of insulinomas. 6. 1 indexed citations
17.
Mukerjee, D, Edward Kingdon, Mark Vanderpump, & Gerry Coghlan. (2003). Pathophysiological insights from a case of reversible pulmonary arterial hypertension. Journal of the Royal Society of Medicine. 96(8). 403–404. 7 indexed citations
18.
Vanderpump, Mark. (2003). Subclinical hypothyroidism: the case against treatment. Trends in Endocrinology and Metabolism. 14(6). 262–266. 30 indexed citations
19.
Skinner, Vernon, Tricia Tan, Balasubramaniam Ramesh, et al.. (2003). Ghrelin Can Bind to a Species of High Density Lipoprotein Associated with Paraoxonase. Journal of Biological Chemistry. 278(11). 8877–8880. 116 indexed citations
20.
Kingdon, Edward, et al.. (2001). Glomeruloid haemangioma and POEMS syndrome. Nephrology Dialysis Transplantation. 16(10). 2105–2107. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026